Satter Muneer A (CIK 0001315797)

Latest company ownership

Shares held
16,609,449
Last filed at
Jan 8, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
ANNX - Annexon, Inc.
Role: Director
Shares held
9,728,637
Last filed at
Nov 21, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
3,037,042
Last filed at
Jul 11, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Shares held
765,328
Last filed at
Sep 24, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q3 2025Q4
Shares held
21,400
Last filed at
Jun 19, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
IMUX - IMMUNIC, INC.
Role: Director
Shares held
0
Last filed at
Sep 17, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 20, 2025 Nov 21, 2025 Annexon, Inc. Director Buy 95.0 +822,613 9.24% ✗ $3.6M
Nov 17, 2025 Nov 19, 2025 Annexon, Inc. Director Buy 100.0 +1,500,000 20.25% ✗ $5.1M
Dec 26, 2023 Dec 28, 2023 Annexon, Inc. Director Buy 92.5 +350,000 4.96% ✗ $1M
Feb 10, 2023 Feb 14, 2023 Annexon, Inc. Director Buy 100.0 +2,647,058 60.04% ✗ $18M
Jul 7, 2022 Jul 11, 2022 Annexon, Inc. Director Buy 100.0 +2,453,988 125.53% ✗ $9.4M
Jan 8, 2021 Jan 8, 2021 Rein Therapeutics, Inc. Officer Buy 100.0 +9,000,000 118.27% ✗ $9.9M
Jul 28, 2020 Jul 28, 2020 Annexon, Inc. Director Buy 100.0 +200,000 11.40% ✗ $3.4M
Jun 8, 2020 Jun 9, 2020 Rein Therapeutics, Inc. Director Buy 100.0 +3,700,000 94.64% ✗ $4.1M
Jan 8, 2019 Jan 10, 2019 Whitehawk Therapeutics, Inc. Director Buy 82.5 +63,818 1.15% ✗ $150.3K
Jan 3, 2019 Jan 7, 2019 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.09% ✗ $127.5K
Dec 28, 2018 Jan 2, 2019 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.10% ✗ $108.1K
Dec 21, 2018 Dec 27, 2018 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.12% ✗ $104.1K
Dec 18, 2018 Dec 20, 2018 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.13% ✗ $115.2K
Dec 12, 2018 Dec 14, 2018 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.14% ✗ $121.3K
Dec 7, 2018 Dec 11, 2018 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.15% ✗ $127.2K
Dec 3, 2018 Dec 6, 2018 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.17% ✗ $125.4K
Nov 28, 2018 Nov 30, 2018 Whitehawk Therapeutics, Inc. Director Buy 82.5 +60,000 1.18% ✗ $118.5K
Sep 13, 2018 Sep 17, 2018 IMMUNIC, INC. Director Sell 17.5 -11,382,277 -100.00% ✗ $4.1M
Jun 28, 2018 Jun 29, 2018 Whitehawk Therapeutics, Inc. Director Buy 100.0 +1,818,182 55.78% ✗ $7M
Mar 21, 2018 Mar 23, 2018 Whitehawk Therapeutics, Inc. Director Buy 56.3 +5,000 0.15% ✗ $24.4K
Mar 19, 2018 Mar 21, 2018 Whitehawk Therapeutics, Inc. Director Buy 65.0 +13,000 0.40% ✗ $64.6K
Dec 12, 2017 Dec 14, 2017 IMMUNIC, INC. Director Buy 75.0 +100,000 0.89% ✗ $548.3K
Dec 7, 2017 Dec 11, 2017 IMMUNIC, INC. Director Buy 85.0 +150,000 1.35% ✗ $733.1K
Sep 12, 2017 Sep 14, 2017 IMMUNIC, INC. Director Buy 85.0 +130,000 1.18% ✗ $521.2K
Sep 8, 2017 Sep 12, 2017 IMMUNIC, INC. Director Buy 65.0 +50,000 0.46% ✗ $176.6K
Jul 5, 2017 Jul 11, 2017 Akebia Therapeutics, Inc. Director Buy 100.0 +1,034,482 51.66% ✗ $15M
Jul 5, 2017 Jul 6, 2017 Rein Therapeutics, Inc. 10% Owner Buy 97.5 +33,333 23.02% ✗ $500K
Jun 13, 2017 Jun 14, 2017 IMMUNIC, INC. Director Buy 60.0 +20,000 0.18% ✗ $61.3K
Jun 8, 2017 Jun 12, 2017 IMMUNIC, INC. Director Buy 65.0 +30,000 0.28% ✗ $93.3K
Jun 6, 2017 Jun 7, 2017 IMMUNIC, INC. Director Buy 60.0 +20,000 0.18% ✗ $64K
Mar 27, 2017 Mar 27, 2017 IMMUNIC, INC. Director Buy 100.0 +3,750,000 52.58% ✗ $15M
Mar 15, 2017 Mar 17, 2017 Whitehawk Therapeutics, Inc. Director Buy 100.0 +1,120,000 52.78% ✗ $5.6M
Oct 28, 2015 Oct 29, 2015 IMMUNIC, INC. Director Buy 95.0 +400,000 5.94% ✗ $2.2M
Apr 22, 2015 Apr 22, 2015 Akebia Therapeutics, Inc. Director Buy 100.0 +420,000 26.54% ✗ $3.5M
Nov 25, 2014 Nov 26, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $65.9K
Nov 24, 2014 Nov 25, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $69.4K
Nov 21, 2014 Nov 24, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $73.7K
Nov 20, 2014 Nov 21, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $73.5K
Nov 19, 2014 Nov 20, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $74.3K
Nov 18, 2014 Nov 19, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $69.2K
Nov 17, 2014 Nov 18, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $64.7K
Nov 14, 2014 Nov 17, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.32% ✗ $59.6K
Nov 13, 2014 Nov 14, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.33% ✗ $57.8K
Nov 12, 2014 Nov 13, 2014 Akebia Therapeutics, Inc. Director Buy 65.0 +5,000 0.33% ✗ $59.5K
Oct 8, 2014 Oct 9, 2014 IMMUNIC, INC. Director Buy 87.5 +74,286 1.12% ✗ $1.3M
Sep 22, 2014 Sep 24, 2014 Eledon Pharmaceuticals, Inc. 10% Owner Buy 95.0 +150,000 9.25% ✗ $2.3M
Jun 2, 2014 Jun 4, 2014 IMMUNIC, INC. Director Buy 65.0 +14,500 0.22% ✗ $190.8K
Apr 23, 2014 Apr 23, 2014 IMMUNIC, INC. Director Buy 95.0 +360,966 5.75% ✗ $4.3M
Mar 25, 2014 Mar 27, 2014 Akebia Therapeutics, Inc. Director Buy 95.0 +91,295 6.33% ✗ $1.6M